Risk factors and mortality associated with Clostridium difficile-associated diarrhoea at a VA hospital

被引:28
作者
Changela, U
Cannon, JP
Aneziokoro, C
Shah, PS
Thottapurathu, L
Lentino, J [1 ]
机构
[1] Loyola Univ, Chicago Med Ctr, Div Infect Dis, Maywood, IL 60153 USA
[2] Edward Hines Jr VA Hosp, Serv Pharm, Hines, IL 60141 USA
[3] Edward Hines Jr VA Hosp, Infect Dis Sect Med Serv, Hines, IL 60141 USA
[4] St Lukes Hosp, Mayo Clin, Dept Pharm, Jacksonville, FL USA
[5] Edward Hines Jr VA Hosp, Cooperat Studies Program Coordinating Ctr, Hines, IL USA
关键词
Clostridium difficile; antibiotics; mortality; risk factors;
D O I
10.1016/j.ijantimicag.2004.07.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The objective of this study was to evaluate the risk of certain patient co-morbidities and antibiotics in the development of Clostridium difficile-associated diarrhoea (CDAD). Hospitalized patients developing CDAD during a specified period were compared with a cohort of patients, matched by age, without a diagnosis of CDAD, who were hospitalized during the same time period. Data collection included demographics, hospital ward, co-morbid conditions, antibiotics received, and mortality. Gender and age were similar in both groups. Comorbid conditions significantly associated with the case group included cancer and COPD. The most commonly prescribed antibiotics in the case versus control group included levofloxacin, intravenous vancomycin, clindamycin, and piperacillin/tazobactam. The case group was associated with a higher mortality rate. Published by Elsevier B.V. and the International Society of Chemotherapy.
引用
收藏
页码:562 / 566
页数:5
相关论文
共 15 条
[1]   Epidemiology of Clostridium difficile-associated infections [J].
Barbut, F ;
Petit, JC .
CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (08) :405-410
[2]   ANTIBIOTIC-ASSOCIATED DIARRHEA [J].
BARTLETT, JG .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (04) :573-581
[3]   Recurrent Clostridium difficile disease following ciprofloxacin use [J].
Bauwens, JE ;
McFarland, LV ;
Melcher, SA .
ANNALS OF PHARMACOTHERAPY, 1997, 31 (09) :1090-1090
[4]   Risk factors for Clostridium difficile infection [J].
Bignardi, GE .
JOURNAL OF HOSPITAL INFECTION, 1998, 40 (01) :1-15
[5]   Epidemiology of Clostridium difficile infection in a large population of hospitalized US military veterans [J].
Buchner, AM ;
Sonnenberg, A .
DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (01) :201-207
[6]   PSEUDOMEMBRANOUS COLITIS ASSOCIATED WITH CIPROFLOXACIN [J].
CAIN, DB ;
OCONNOR, ME .
LANCET, 1990, 336 (8720) :946-946
[7]   Moxifloxacin-induced Clostridium difficile-associated diarrhea [J].
Carroll, DN .
PHARMACOTHERAPY, 2003, 23 (11) :1517-1519
[8]  
DAN M, 1989, AM J MED, V87, P479
[9]   The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea [J].
Hurley, BW ;
Nguyen, CC .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (19) :2177-2184
[10]   Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. [J].
Johnson, S ;
Samore, MH ;
Farrow, KA ;
Killgore, GE ;
Tenover, FC ;
Lyras, D ;
Rood, JI ;
DeGirolami, P ;
Baltch, AL ;
Rafferty, ME ;
Pear, SM ;
Gerding, DN .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (22) :1645-1651